STAA - STAAR Surgical Company

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue82,43277,12374,987
Cost of Revenue24,06324,40026,164
Gross Profit58,36952,72348,823
Operating Expenses
Research Development20,29414,76112,363
Selling General and Administrative50,73043,29944,487
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-12,655-5,337-8,027
Income from Continuing Operations
Total Other Income/Expenses Net326-140-464
Earnings Before Interest and Taxes-12,329-5,477-8,491
Interest Expense115128154
Income Before Tax-12,444-5,605-8,645
Income Tax Expense-315928-253
Minority Interest---
Net Income From Continuing Ops-12,129-6,533-8,392
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-12,129-6,533-8,392
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-12,129-6,533-8,392